Advertisement IRIC uses Roche xCELLigence SP Instrument in drug-induced cellular activity study - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

IRIC uses Roche xCELLigence SP Instrument in drug-induced cellular activity study

The Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal in Quebec, Canada, has used the Roche xCELLigence SP Instrument to measure changes in cell response following ligand stimulation.

The study finds selective pharmacological inhibition of specific arms of the ß2AR signaling network to correlate the differential contribution of signaling events to specific components of the cell response.

The essential role of intracellular Ca2+ in the cell response also led to the discovery of a novel ß2AR-promoted Ca2+ mobilization event, the researchers reported.

The study emphasizes the power of using cell monitoring to dissect the pluridimensionality of GPCR signaling using integrative approaches for a comprehensive readout of drug-induced cellular activity.